Aripiprazole induced acute dystonia after discontinuation of a stimulant medication

Journal of Clinical Psychopharmacology

Volumn 30, Issue 1, 2010, Pages 77-78

  McLaren, Jennifer L ^a   Cauble, Steven ^a   Barnett, R Joffree ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZATROPINE; LITHIUM CARBONATE; METHYLPHENIDATE;

ACUTE DISEASE; CASE REPORT; CHILD; DRUG FORMULATION; DYSTONIA; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DRUG ADMINISTRATION SCHEDULE; DYSTONIA; HUMANS; MALE; METHYLPHENIDATE; PIPERAZINES; QUINOLONES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 74549126624     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181c92eb2     Document Type: Letter

References (11)

1. Safer D, Zito JM, DosReis S. Concomitant psychotropic medications for youths. Am J Psychiatry. 2003;160:438-449.
2. Benjamin E, Salek S. Stimulant-atypical antipsychotic interaction and acute dystonia. J Am Acad Child Adolesc Psychiatry. 2005;44:510-511.
3. Keshen A, Carandang C. Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued. J Child Adolesc Psychopharmacol. 2007;17:867-869.
4. Levine J, Deneys M, Benjamin S. Dystonia with combined antipsychotic and stimulant treatment. J Am Acad Child Adolesc Psychiatry. 2007;46:665-666.
5. Singh M, DelBello M, Adler C. Acute dystonia associated with aripiprazole in a child. J Am Acad Child Adolesc Psychiatry. 2007;46:306-307.
6. Shen Y. Amphetamine as a risk factor for aripiprazole-induced acute dystonia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1756-1757.
7. Burris KD, Molski TF, Xu C, et al. Aripirazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther. 2002;302:381-389.
8. 11C]raclopride. Neuropsychopharmacology. 2002;27:248-259.
9. Weiss B, Zhou LW, Davidkova G. Pharmacologic and molecular refulation of the expression of dopamine receptors. In: Merchank K, ed. Pharmacological Regulation of Gene Expression in the CNS. Boca Raton, FL: CRC Press; 1996;8:181.
10. Wolfson LI, Sharpless NS, Thal LJ, et al. Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia. Neurology. 1983;33:369-372.
11. Lutes J, Lorden JF, Oltmans GA. The effect of clonidine on the motor syndrome of the genetically dystonic rat. Sot Neurosci Abstr. 1985;11:670.